Clinical Trial Update: Nicotine Pharmacokinetic and Pharmacodynamics Profile, Safety and Tolerability of P3L [NA]

View source ↗

Summary

A completed clinical trial evaluating the nicotine pharmacokinetic and pharmacodynamic profile, safety and tolerability of P3L for smoking; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking

Drugs mentioned

• P3L

Snippet

Sponsor: Philip Morris Products S.A. | Conditions: Smoking | NA | Status: COMPLETED | Results posted: 2017-06-15